Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Jean-Pierre Pouget

DR2 INSERM, Team Leader

Institut de Recherche en Cancérologie de Montpellier

France

Research Interests

Explore related searches

Professors in France

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Fijs van leeuwen

Professor and head of the Interventional Molecular Imaging Laboratory

Leiden University Medical Center

NETHERLANDS

View details

Emmanuel Deshayes

University of Montpellier

FRANCE

View details

Tanguy Haute

Université de Bretagne Occidentale

FRANCE

View details

Matthias D'Huyvetter

Vrije Universiteit Brussel

BELGIUM

View details

Marie Morille

Associate Professor

FRANCE

View details

Michael Lassmann

Professor

Julius-Maximilians-Universität Würzburg Medizinische Fakultät

GERMANY

View details

Sophie Poty

Junior Professor (Chaire Professeur Junior)

Université Bourgogne Europe

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jean-Pierre Pouget

Research Interests

Explore related searches

Articles (13)

Surface modification of extracellular vesicles with polyoxazolines to enhance their plasma stability and tumor accumulation

MHC-I–Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy

EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed doses

Development of an <i>in vivo</i> ovarian cancer peritoneal carcinomatosis model for radioimmunotherapy testing

Optimizing the Therapeutic Index of sdAb-Based Radiopharmaceuticals Using Pretargeting

Absorbed Dose-Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [<sup>177</sup>Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine

An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine.

Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy.

Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors

Clonogenic assay to measure bystander cytotoxicity of targeted alpha-particle therapy

Immunomodulatory effects of targeted radionuclide therapy

Radiobiology of targeted radionuclide therapy

The Radiobiology of Radiopharmaceutical Therapy: The Input of Imaging and Radiomics

Collaborators (7)

Fijs van leeuwen

Emmanuel Deshayes

Tanguy Haute

Matthias D'Huyvetter

Marie Morille

Michael Lassmann

Sophie Poty

Make your next move.